Three-Year Patient-Reported Outcomes From Bimekizumab for Plaque Psoriasis
Bengt Hoepken, Balint Szilagyi, Jérémy Lambert, William Harold Dawe et al.
Journal
JAMA Dermatology
Topics
Psoriasis: Treatment and Pathogenesis
article
Three-Year Patient-Reported Outcomes From Bimekizumab for Plaque Psoriasis
Bengt Hoepken, Balint Szilagyi, Jérémy Lambert, William Harold Dawe, Rhys Warham, Anna López-Ferrer, Alice B. Gottlieb, Ronald Vender, Steven R. Feldman, Matthias Augustin, Richard B. Warren, April Armstrong
article en
Abstract
No abstract available for this paper.
Publication Tag
JAMA Dermatology
Institutions
Universität Hamburg (DE), University of California, Los Angeles (US), Manchester Academic Health Science Centre (GB), Salford Royal NHS Foundation Trust (GB), Hospital de Sant Pau (ES), University College Birmingham (GB), National Psoriasis Foundation (US), ASIS Foundation (US), UCB Pharma (France) (FR), University Medical Center Hamburg-Eppendorf (DE), Parliament of United Kingdom (GB), Dermatrials Research (CA), NIHR Manchester Biomedical Research Centre (GB), UCB Pharma (Germany) (DE), Wake Forest University (US), The University of Texas Southwestern Medical Center (US)
Funders
Amgen, Bristol-Myers Squibb, National Institute for Health and Care Research, Galderma, Manchester Biomedical Research Centre